
    
      This is a double-blind randomized clinical trial which will start at June 2014 and end on
      June 2015 in Isfahan city. Serum creatinine level is considered as a key variable and the
      sample size calculated 80 persons (40 persons for control group and 40 persons for patient
      group).
    
  